CYSB2500042 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2025-02-15 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CYSB2500003 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2025-01-04 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CYSB2101259 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2021-11-09 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CYSB2100072 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2021-03-19 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-03-18 | view |
CXSS2300091 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2023-12-06 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSS2101063 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-12-15 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSS2100032 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-26 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Completed-Pending Issued | 2021-12-10 | view |
CXSS2100031 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-03-26 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Completed-Pending Issued | 2021-12-10 | view |
CXSS2000055 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2020-11-12 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-11-11 | view |
CXSS2000045 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2020-09-04 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-09-03 | view |
CXSS1900035 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-09-12 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2020-06-22 | view |
CXSS1900034 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-09-12 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2020-06-22 | view |
CXSS1900023 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-05-16 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2020-03-06 | view |
CXSS1800009 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2018-04-23 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd;Jiangsu Hengrui Pharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2019-06-03 | view |
CXSL2500135 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2025-02-12 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSL2400047 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2024-01-20 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSL2101385 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-10-26 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSL2101340 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-09-23 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSL2101321 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-09-13 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
CXSL2101254 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(2.2) | New Drug Application | 2021-08-11 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |